SPONSOR
The Affiliated Hospital of Xuzhou Medical University
Total Trials
5
Recruiting
5
Phases
Phase 2, Phase 1, Phase 2, Phase 1
Conditions studied: Angioimmunoblastic T-Cell Lymphoma RecurrentAngioimmunoblastic T-Cell Lymphoma RefractoryOvarian CancerHepatocellular CarcinomaNon-muscle Invasive Bladder CancerAdvanced Solid Tumors
NCT07058103 Phase 2
Recruiting
Tislelizumab , Cyclophosphamide, Mitoxantrone Liposomes, Chidamide, and Prednisone in the Treatment of R/R AITL
Angioimmunoblastic T-Cell Lymphoma Recurrent
NCT05211557 Phase 1, Phase 2
Recruiting
Study of Fully Human B7H3 CAR-T in Treating Recurrent Malignant Ovarian Cancer
Ovarian Cancer
NCT05323201 Phase 1, Phase 2
Recruiting
Study Of B7H3 CAR-T Cells in Treating Advanced Liver Cancer
Hepatocellular Carcinoma
NCT06632964 Phase 1
Recruiting
A Clinical Trial Aimed At Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder Cancer
Non-muscle Invasive Bladder Cancer
NCT07285395 Phase 1
Recruiting
AT1019 Plus SBRT and PD-1 Inhibitor for Advanced Solid Tumors: An IIT Study
Advanced Solid Tumors